Skip to main content

Table 4 Initial postoperative recurrence site details in patients with or without clinical mediastinal/abdominal lymph node metastases

From: Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study

Initial recurrence pattern

Variables

 

All patients (N = 157)

(Recurrence sitea)

cMLNMb

cALNMc

Absent (N = 106)

Present (N = 51)

Absent (N = 112)

Present (N = 45)

Locoregional recurrence

Absent

 

127

 

90

 

37

 

93

 

34

 

Present

Cervical lymph node

30

(11)

16

(6)

14

(5)

19

(5)

11

(6)

Mediastinal local or lymph node

(25)

(12)

(13)

(13)

(12)

Abdominal lymph node

(10)

(7)

(3)

(5)

(5)

Systemic recurrence

Absent

 

132

 

93

 

39

 

102

 

30

 

Present

Lung

25

(9)

13

(4)

12

(5)

10

(3)

15

(6)

Liver

(6)

(3)

(3)

(2)

(4)

Para-abdominal aortic lymph node

(6)

(5)

(1)

(2)

(4)

Pleura

(9)

(3)

(6)

(4)

(5)

Others (Adrenal gland, bone, or ventricle)

(4)

(2)

(2)

(1)

(3)

  1. aIncluding duplications, bcMLNM clinical mediastinal lymph node metastasis, ccALNM clinical abdominal lymph node metastasis